1. Home
  2. BLTE vs SEE Comparison

BLTE vs SEE Comparison

Compare BLTE & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$158.49

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Sealed Air Corporation

SEE

Sealed Air Corporation

HOLD

Current Price

$42.15

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
SEE
Founded
2018
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.2B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BLTE
SEE
Price
$158.49
$42.15
Analyst Decision
Strong Buy
Buy
Analyst Count
7
11
Target Price
$198.00
$43.50
AVG Volume (30 Days)
117.4K
3.2M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
89.50
EPS
N/A
3.43
Revenue
N/A
$5,359,800,000.00
Revenue This Year
N/A
$1.93
Revenue Next Year
$492.11
$2.27
P/E Ratio
N/A
$12.29
Revenue Growth
N/A
N/A
52 Week Low
$56.68
$27.34
52 Week High
$200.00
$44.27

Technical Indicators

Market Signals
Indicator
BLTE
SEE
Relative Strength Index (RSI) 43.63 65.73
Support Level $157.63 $41.79
Resistance Level $161.28 $42.21
Average True Range (ATR) 6.26 0.08
MACD -1.15 0.02
Stochastic Oscillator 17.27 100.00

Price Performance

Historical Comparison
BLTE
SEE

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About SEE Sealed Air Corporation

Sealed Air Corp is a provider of packaging solutions that integrate sustainable, high-performance materials, automation, equipment, and services. The company designs, manufactures, and delivers packaging solutions that preserve food, protect goods, and automate packaging processes. It delivers its packaging solutions to an array of end markets including fresh proteins, foods, fluids and liquids, medical and life science, e-commerce retail, logistics and omnichannel fulfillment operations, and industrials. It has two reportable segments, Food and Protective. The company generates majority of its revenue from the food segment.

Share on Social Networks: